Skip to main content
. 2018 Oct 2;11(1):166–177. doi: 10.1080/19420862.2018.1524664

Figure 6.

Figure 6.

Pharmacokinetic study on Fab13.7 and half-life engineered variants.

PK profiles were obtained after i.v. bolus injection of 25 µg protein using C57BL/6J mice (n = 3) homozygously bearing the extracellular domain of human TNFR1 at the locus of the mouse gene. Initial and terminal half-lifes as well as the area under the curve were calculated after detection of remaining active protein in serum samples by ELISA.